Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients
US10962552B2 · kind B2 · utility
1Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 10, 2020 |
| Grant date | Mar 30, 2021 |
| Priority date | — |
| Expiry date | Mar 10, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/60
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are methods for assessing risk of infection or cardiovascular disease (CVD) in a subject with an inflammatory disease, e.g., rheumatoid arthritis. The methods include performing immunoassays to generate scores based on quantitative data for expression of biomarkers relating to inflammatory biomarkers with or without additional clinical variables to assess infection and CVD risk. Also provided are uses of inflammatory biomarkers for guiding treatment decisions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.